Evolent Health Inc Class A EVH 深 沪
等待开盘 05-12 09:30:00 美东时间
3.835
-0.345
-8.25%
华盛通- 最 高4.535
- 今 开4.27
- 成交量 333.53万股
- 最 低 3.555
- 昨 收 4.18
- 总市值 35.13万
- 52周最高 12.065
- 市盈率 静 --
- 换手率 3641.33%
- 52周最低 2.095
- 委 比 47.34%
- 总股本 9.16万
- 历史最高 39.779
- 量 比 1.54
- 振 幅 23.44%
- 历史最低 2.095
- 每 手 1
- 风险率 2.96%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Keybanc Downgrades Evolent Health to Sector Weight
Keybanc analyst Matthew Gillmor downgrades Evolent Health (NYSE:EVH) from Overweight to Sector Weight.
02-25 19:25
BTIG Maintains Buy on Evolent Health, Lowers Price Target to $10
BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $16 to $10.
02-02 18:40
Morgan Stanley Adds Eaton Vance ETF Targeting High-Income, Diversified Bond Opportunities
Morgan Stanley has expanded its ETF lineup with a newly converted fund targeting high income and diversified global bond exposure.
2025-11-13 04:40
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
Privia Health收购Evolent的ACO业务以强化价值医疗模式
Privia Health Group， Inc． PRVA 周二同意从Evolent Health， Inc． EVH 收购其负责任医疗组织业务。 Privia Health将在交易完成时支付1亿美元现金，并可能根据2025年医疗保险共享储蓄计划的最终绩效最高再支付1300万美元。 该交易预计将于2025年第四季度完成，并有望在2026年对调整后税息折旧及摊销前利润产生积极贡献。 海量资讯、精准解读，尽在新浪财经APP 责任编辑：张俊 SF065
2025-09-25 02:17
26辆氢车获国补1100万，亿华通配套近70%
（来源：氢能源燃料电池电动汽车） 8月5日，工业和信息化部正式发布了关于2016—2020年度新能源汽车推广应用补助资金清算审核终审结果以及2021—2022年...
2025-08-11 09:58
Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock
Throughout the last three months, 18 analysts have evaluated Evolent Health (NY...
2025-03-11 05:04
AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?
The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, Iovance Biotherapeutics, Evolent Health, Semtech Corp, AST SpaceMobile.
2024-09-09 02:09
Truist Securities Maintains Buy on Evolent Health, Maintains $33 Price Target
Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and maintains $33 price target.
2024-08-27 22:17
Evolent Health's Standardized, Formulaic Pricing Approaches to Help Manage Volatility Going Forward, RBC Says
11:31 AM EDT, 08/26/2024 (MT Newswires) -- Evolent Health (EVH) has developed standardized and formulaic pricing methods that will help the company "manage volatility going forward" as it also reportedly received takeover interest from several private equity firms, RBC Capital Markets said in a note...
2024-08-26 23:31
